Carlos J. Toro-Huamanchumo

@CarlosToro_29

Peruvian MD Epidemiologist and Research Professor. Interests in Public Health & Epidemiology, NCDs (Obesity & Metabolism), Mental Health and Medical Education

Chiclayo, Perú
Joined September 2014
24 Photos and videos Photos and videos

Tweets

You blocked @CarlosToro_29

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @CarlosToro_29

  1. Retweeted
    Aug 27

    Finalmente! Publicado nuestro artículo sobre Prevalencia y factores asociados a la intención de vacunarse contra COVID en el Perú Debemos diseñar políticas que mitiguen la reticencia para ello necesitamos información de calidad

    , and
    11 replies 113 retweets 297 likes
    Show this thread
    Show this thread
    Undo
  2. Retweeted
    Aug 27

    I have made my lectures notes on Statistical Inference publicly available. I have written these notes throughout several years. Disclaimer: These notes should not be distributed or used for commercial purposes.

    9 replies 60 retweets 329 likes
    Undo
  3. Retweeted
    Aug 20

    El gran Carlitos Toro

    1 retweet 5 likes
    Undo
  4. Retweeted
    Aug 19

    ¿Cómo pueden las agencias de ETESA priorizar que tecnologías evaluar? Resultados del Latam Policy Forum publicados ahora en disponibles en inglés () y español ()

    https://cup.org/3y2EDSw
    14 retweets 19 likes
    Undo
  5. Retweeted
    Aug 18

    What's the minimum sample size you need to develop a new prediction model with a continuous, binary, or time-to-event outcome? Thanks to , there's now a full-blown package to figure it out. Comes with very detailed and didactic documentation.😎

    pmsampsize update now available in & Use C statistic from existing binary outcome model to calculate minimum sample size required for a new prediction model development study Based on 👉
    1 reply 20 retweets 45 likes
    Show this thread
    Show this thread
    Undo
  6. Retweeted
    Jun 28

    pmsampsize update now available in & Use C statistic from existing binary outcome model to calculate minimum sample size required for a new prediction model development study Based on 👉

    4 replies 40 retweets 213 likes
    Undo
  7. Retweeted
    Aug 11

    A fin de impulsar el desarrollo de la investigación científica en el Seguro Social, el titular de EsSalud, Dr. Mario Carhuapoma, sostuvo un encuentro con los integrantes del IETSI - EsSalud, quienes recibieron el respaldo del titular para continuar con sus investigaciones.

    , , and 6 others
    19 replies 42 retweets 245 likes
    Undo
  8. Retweeted
    Aug 9

    Aunque sabemos que la reinfección por , es un evento muy raro afortunadamente, en se publican datos de la importancia de vacunar a las personas con antecedente de COVID-19. El riesgo de infección es 2,3 veces más alto en los NO vacunados vs los vacunados.

    7 replies 75 retweets 149 likes
    Show this thread
    Show this thread
    Undo
  9. Retweeted
    Aug 9

    Thanks to the for the post!

    Former Fogarty Fellow is using to make a difference in .
    3 retweets 13 likes
    Undo
  10. Retweeted
    Aug 7

    📕 Recomendación de lectura del día: Nueva definición para la enfermedad del hígado graso asociada a disfunción metabólica: una declaración de consenso de expertos internacionales.

    2 replies 116 retweets 412 likes
    Show this thread
    Show this thread
    Undo
  11. Retweeted
    Aug 2

    Ahora que tengo algo de tiempo, he preparado un hilo con herramientas online y apps gratuitas para vuestras presentaciones. 🤓 Tened en cuenta que no son solo para hacer diapositivas, sino para preparar una charla y exponerla. Así que hay de todo. 😉 EMPEZAMOS 👇👇👇

    291 replies 8,287 retweets 30,306 likes
    Show this thread
    Show this thread
    Undo
  12. Retweeted
    Jul 31

    Crossed the 300 peer review publication mark recently Here is what I learned over 12 years of publishing 1. Don't include too many authors... You have to type their name, affiliation AND email into those damn submission portals God help 30+ collaborators!

    20 replies 124 retweets 575 likes
    Show this thread
    Show this thread
    Undo
  13. Retweeted
    Jul 31

    hay grupos y temas específicos que requieren especial atención. Hace poco publicamos un estudio en en el que encontramos que en la región si bien hay una alta intención a vacunarse: 80%

    2 replies 7 retweets 17 likes
    Show this thread
    Show this thread
    Undo
  14. Retweeted
    Jul 30

    ¡La convocatoria para está abierta! Dada la coyuntura actual, este año únicamente se darán pasantías virtuales en 5 ramas. El proceso de selección consta de 3 fases y los resultados serán comunicados por email. (1/2)

    1 reply 19 retweets 25 likes
    Show this thread
    Show this thread
    Undo
  15. Jul 26

    Presenting our study on the Third Scientific Sunday

    1 retweet 2 likes
    Undo
  16. Retweeted
    Jul 26

    Just published Mix and match AZ (vector) vaccine: Adding mRNA (as 2nd dose) led to a better immune response than 2 AZ doses and CD8+ T cells was even better than 2 mRNA doses. And well tolerated Prior tweet deleted (not J&J), sorry, too early in the morning here

    72 replies 876 retweets 2,125 likes
    Show this thread
    Show this thread
    Undo
  17. Retweeted
    Jul 25

    Tune in for the coming TUGS Lounge discussing decision making in 1ry & revisional antireflux surgery. 05/08 20:00 BST. Register here:

    , , and 5 others
    10 retweets 23 likes
    Undo
  18. Retweeted
    Jul 22

    A mentor’s love for their trainees can be measured in tracked changes

    285 replies 1,780 retweets 14,717 likes
    Undo
  19. Retweeted
    Jul 20

    Abstracts are now open for the Engaging Evidence event, presented by the regional groups of Cochrane, JBI, GRADE & GIN in November. Find out more on the website:

    6 retweets 8 likes
    Undo
  20. Retweeted
    Jul 16

    Lifestyle modifications for people with nonalcohol‐related fatty liver disease New systematic review looks at the evidence from 59 RCTs.

    3 retweets 4 likes
    Undo

@CarlosToro_29 hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·